Lin-Fen Hsieh1,2, James Cheng-Chung Wei3,4,5, Hsin-Yi Lee6, Chih-Cheng Chuang2,7, Jiunn-Song Jiang2,8, Kae-Chwen Chang1. 1. Department of Physical Medicine and Rehabilitation, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. 2. School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan. 3. Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan. 4. Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. 5. Graduated Institute of Integrated Medicine, China Medical University, Taichung, Taiwan. 6. Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University, Taipei, Taiwan. 7. Department of Allergy, Immunology, and Rheumatology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. 8. Department of Chest Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Abstract
AIM: To evaluate aerobic capacity in patients with ankylosing spondylitis (AS) and determine possible relationships between aerobic capacity, pulmonary function, and disease-related variables. METHOD: Forty-two patients with AS and 42 healthy controls were recruited in the study. Descriptive data, disease-related variables (grip strength, lumbosacral mobility, occiput-to-wall distance, chest expansion, finger-to-floor distance, Bath Ankylosing Spondylitis Disease Activity Index, Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and hemoglobin), and chest and thoracic spine x-rays were collected in each patient with AS. All subjects took standard pulmonary function and exercise tolerance tests, and forced vital capacity (FVC) and aerobic capacity were recorded. RESULTS: Both aerobic capacity and FVC in patients with AS were significantly lower than those in normal subjects (P < 0.05). AS patients with BASFI scores of < 3 or BASDI scores of < 4 had a higher aerobic capacity. There was significant correlation between aerobic capacity, vital capacity, chest expansion, Schober's test, cervical range of motion, and BASFI in patients with AS. Neither aerobic capacity nor vital capacity correlated with disease duration, ESR, CRP, and hemoglobin. CONCLUSIONS: Significantly reduced aerobic capacity and FVC were observed in patients with AS, and there was significant correlation between aerobic capacity, vital capacity, chest expansion, and BASFI.
AIM: To evaluate aerobic capacity in patients with ankylosing spondylitis (AS) and determine possible relationships between aerobic capacity, pulmonary function, and disease-related variables. METHOD: Forty-two patients with AS and 42 healthy controls were recruited in the study. Descriptive data, disease-related variables (grip strength, lumbosacral mobility, occiput-to-wall distance, chest expansion, finger-to-floor distance, Bath Ankylosing Spondylitis Disease Activity Index, Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and hemoglobin), and chest and thoracic spine x-rays were collected in each patient with AS. All subjects took standard pulmonary function and exercise tolerance tests, and forced vital capacity (FVC) and aerobic capacity were recorded. RESULTS: Both aerobic capacity and FVC in patients with AS were significantly lower than those in normal subjects (P < 0.05). AS patients with BASFI scores of < 3 or BASDI scores of < 4 had a higher aerobic capacity. There was significant correlation between aerobic capacity, vital capacity, chest expansion, Schober's test, cervical range of motion, and BASFI in patients with AS. Neither aerobic capacity nor vital capacity correlated with disease duration, ESR, CRP, and hemoglobin. CONCLUSIONS: Significantly reduced aerobic capacity and FVC were observed in patients with AS, and there was significant correlation between aerobic capacity, vital capacity, chest expansion, and BASFI.
Authors: Bilge Basakci Calik; Elif Gur Kabul; Harun Taskın; Orcin Telli Atalay; Ummuhan Bas Aslan; Murat Tascı; Fahrettin Bıcakcı; Ali Ihsan Yıldız Journal: Rheumatol Int Date: 2018-06-25 Impact factor: 2.631
Authors: Bas Hilberdink; Thea Vliet Vlieland; Florus van der Giesen; Floris van Gaalen; Robbert Goekoop; Andreas Peeters; Marta Fiocco; Salima van Weely Journal: Rheumatol Int Date: 2020-06-28 Impact factor: 2.631
Authors: Susana A González-Chávez; César Pacheco-Tena; Celia M Quiñonez-Flores; Gerardo P Espino-Solis; Jessica I Burrola-De Anda; Perla M Muñoz-Morales Journal: Bone Joint Res Date: 2020-05-16 Impact factor: 5.853